Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 117
SNMMI 2020: PET/MRI finds location of chronic pain in patients
By
Kate Madden Yee
An imaging technique that combines F-18 FDG PET and MRI was able to pinpoint the origins of chronic pain in patients and help their caregivers develop better management plans, according to a Monday presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.
July 14, 2020
SNMMI 2020: Image of the Year scans reveal 'super-agers'
By
Wayne Forrest
A group of German researchers has received the Image of the Year award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for a series of PET images that show that older adults who maintained peak cognitive skills exhibited greater resistance to buildup of tau and amyloid proteins.
July 13, 2020
SNMMI 2020: AI can aid in diagnosis of Parkinson's disease
By
Erik L. Ridley
An artificial intelligence (AI) algorithm was highly accurate for diagnosing Parkinson's disease on dopamine transporter SPECT exams, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
July 13, 2020
SNMMI 2020: Radionuclide treatment paves way for immunotherapy
By
Brian Casey
Could the administration of an yttrium-90-based radionuclide improve the performance of immunotherapy for prostate cancer? That's the suggestion of an animal study presented at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) virtual meeting.
July 13, 2020
SNMMI taps leaders for 2020-2021 year
By
AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has tapped its leadership slate for the 2020-2021 year at this week's virtual conference.
July 13, 2020
SNMMI 2020: How nuclear medicine handled COVID-19
By
Wayne Forrest
Implementing a proactive, multipronged strategy to combat the COVID-19 pandemic helped Mount Sinai Hospital safeguard its patients and staff as much as humanly possible, according to a Monday presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.
July 13, 2020
SNMMI 2020: Medical students key to the specialty's future
By
Wayne Forrest
The early recruitment of medical students into nuclear medicine and molecular imaging is the key to the specialty's future, said Dr. Vasken Dilsizian during his president's address on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) virtual annual meeting.
July 12, 2020
ITM submits drug master file to FDA for GeGant
By
AuntMinnie.com staff writers
German radiopharmaceutical group ITM Isotopen Technologien München said it has submitted a drug master file to the U.S. Food and Drug Administration (FDA) for its GeGant germanium-68/gallium-68 generator.
July 12, 2020
Spectrum Dynamics debuts new cardiac SPECT system
By
AuntMinnie.com staff writers
Molecular imaging technology developer Spectrum Dynamics Medical has introduced D-SPECT Vista, a digital solid-state cadmium zinc telluride-based cardiac SPECT system.
July 9, 2020
CereHealth highlights population template at SNMMI 2020
By
AuntMinnie.com staff writers
Artificial intelligence software developer CereHealth will present study data on a population template for CereMetrix, the company's brain SPECT imaging software, at the virtual 2020 Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
July 9, 2020
Are community rads supported for oncology imaging?
By
Kate Madden Yee
Although the rate of advanced oncological imaging in specialized, academic cancer centers has increased over the past 15 years, most of these exams continue to be read by radiologists in other practice settings who may not have specific expertise, according to a study published July 5 in the
Journal of the American College of Radiology
.
July 9, 2020
RefleXion, Telix partner on high-risk cancer treatments
By
AuntMinnie.com staff writers
Radiation therapy equipment developer RefleXion Medical and radiopharmaceutical company Telix Pharmaceuticals are investigating the clinical utility of combining their technologies for improving treatments for high-risk prostate and aggressive kidney cancers.
July 7, 2020
Previous Page
Page 117 of 614
Next Page